Hot Pursuit     13-Mar-25
Jubilant Pharmova arm gets EIR from USFDA for Maryland facility
Jubilant Pharmova said that its subsidiary, Jubilant Cadista Pharmaceuticals Inc., USA received the establishment inspection report (EIR) from the US drug regulator for its solid oral formulations facility at Salisbury, Maryland, USA.
The US Food and Drug Administration (USFDA) had classified the inspection as voluntary action indicated (VAI) and confirmed that the inspection is now closed. The inspection took place in January 2025.

As per the company’s previous disclosure on 18 April 2024, the facility is not expected to manufacture any products as it has closed manufacturing operations.

Jubilant Pharmova is engaged in radiopharma, allergy immunotherapy, CDMO of sterile injectable, generics, contract research development and manufacturing (CRDMO) and proprietary novel drugs businesses.

The company's consolidated net profit jumped 51% to Rs 100.90 crore during the quarter as compared with Rs 66.80 crore in Q3 FY24. Net sales increased 8.9% YoY to Rs 1,813.70 crore in Q3 FY25.

The scrip rose 0.32% to Rs 868 on the BSE.

Previous News
  Volumes spurt at Jubilant Pharmova Ltd counter
 ( Hot Pursuit - 13-Mar-25   11:00 )
  Nifty scale above 22,500; PSU bank shares rally
 ( Market Commentary - Mid-Session 13-Mar-25   10:35 )
  Jubilant Pharmova arm gets EIR from USFDA for Maryland facility
 ( Hot Pursuit - 13-Mar-25   10:18 )
  Jubilant Pharmova consolidated net profit rises 51.05% in the December 2024 quarter
 ( Results - Announcements 31-Jan-25   14:39 )
  Jubilant Pharmova announces acquisition of 80% stake in JASMIN
 ( Corporate News - 29-Jan-25   09:03 )
  Jubilant Pharmova to discuss results
 ( Corporate News - 23-Jan-25   14:48 )
  Jubilant Pharmova's Salisbury-based facility gets five observations from US FDA
 ( Hot Pursuit - 17-Jan-25   09:34 )
  Jubilant Cadista's Salisbury unit undergoes USFDA inspection
 ( Corporate News - 17-Jan-25   09:14 )
  Volumes spurt at Jubilant Pharmova Ltd counter
 ( Hot Pursuit - 16-Dec-24   11:00 )
  Jubilant Pharmova consolidated net profit rises 64.48% in the September 2024 quarter
 ( Results - Announcements 25-Oct-24   14:27 )
  Jubilant Pharmova to conduct board meeting
 ( Corporate News - 18-Oct-24   10:41 )
Other Stories
  HDFC Bank Q4 PAT rises 7% YoY to Rs 17,616 cr; NII rises 10%
  19-Apr-25   18:04
  Yes Bank Q4 PAT climbs 63% YoY to Rs 738 cr
  19-Apr-25   16:20
  Mastek Q4 PAT slides 14% QoQ to Rs 81 cr; recommends final dividend of Rs 16/sh
  19-Apr-25   14:31
  Tata Elxsi posts PAT of Rs 172 crore in Q4; EBITDA margin at 20.5%
  19-Apr-25   12:47
  Mahindra EPC records more than fourfold rise in Q4 PAT
  19-Apr-25   11:04
  Just Dial Q4 PAT climbs 36% YoY to Rs 158 cr
  19-Apr-25   10:02
  Jio Financial Services Q4 PAT rises 2% YoY to Rs 316 cr
  19-Apr-25   08:57
  HDFC Life Q4 PAT climbs 16% YoY to Rs 476 cr
  17-Apr-25   17:32
  Infosys Q4 PAT rises 3% QoQ to Rs 7,038 cr; declares dividend of Rs 22/sh
  17-Apr-25   17:25
  HDFC AMC rises after Q4 PAT jumps 18% YoY to Rs 639 cr; declares final dividend of Rs 90/sh
  17-Apr-25   17:11
Back Top